NeoGenomics Neo Comprehensive - Heme Cancers, NSCLC Panel

NeoGenomics has made available two new cancer tests: Neo Comprehensive - Heme Cancers, a next-generation sequencing panel for comprehensive genomic profiling of hematologic malignancies, and the Early-stage Non-Small Cell Lung Cancer Panel, a therapy selection panel designed specifically for early-stage NSCLC patients. The firm said the NSCLC panel provides easy-to-interpret reports and a seven-day turnaround time.